$97.08
0.030.03%
Pre-Market: 4:35 AM EDT
Comments
Loading...
BioNTech Earnings Estimates, EPS & Revenue | NASDAQ:BNTX | Benzinga
BioNTech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 10
EPS
$1.150
Quarterly Revenue
$1.27B
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$2.75B
Analyze the earnings history of BioNTech using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BNTX | BioNTech | -$1.42 | — | — | — | $203.74M | $194.33M | — | — | 05/05/2025 | Get Alert |
| BNTX | BioNTech | $2.04 | $0.37 | $1.15 | 210.81% | $1.59B | $1.15B | $1.27B | 10.43% | 03/10/2025 | Get Alert |
| BNTX | BioNTech | $0.73 | -$1.67 | $0.89 | 153.29% | $974.49M | $639.12M | $1.37B | 114.04% | 11/04/2024 | Get Alert |
| BNTX | BioNTech | -$0.86 | -$2.20 | -$3.62 | -64.55% | $182.78M | $170.40M | $138.56M | -18.69% | 08/05/2024 | Get Alert |
| BNTX | BioNTech | $2.20 | -$1.17 | -$1.42 | -21.37% | $1.37B | $460.50M | $203.74M | -55.76% | 05/06/2024 | Get Alert |
| BNTX | BioNTech | $9.45 | $2.64 | $2.04 | — | $4.37B | $1.99B | $1.59B | -20.00% | 03/20/2024 | Get Alert |
| BNTX | BioNTech | $7.04 | $0.62 | $0.73 | 17.74% | $3.49B | $1.06B | $974.49M | -8.07% | 11/06/2023 | Get Alert |
| BNTX | BioNTech | $6.87 | -$0.75 | -$0.86 | -14.67% | $3.41B | $786.22M | $182.78M | -76.75% | 08/07/2023 | Get Alert |
| BNTX | BioNTech | $14.24 | $0.16 | $2.20 | 1275.00% | $6.37B | $1.60B | $1.37B | -14.31% | 05/08/2023 | Get Alert |
| BNTX | BioNTech | $12.18 | $8.61 | $9.45 | 9.76% | $5.53B | $4.25B | $4.37B | 2.75% | 03/27/2023 | Get Alert |
| BNTX | BioNTech | $12.35 | $4.42 | $7.04 | 59.28% | $6.09B | $2.03B | $3.49B | 71.87% | 11/07/2022 | Get Alert |
| BNTX | BioNTech | $12.97 | $7.36 | $6.87 | -6.66% | $6.39B | $4.09B | $3.41B | -16.70% | 08/08/2022 | Get Alert |
| BNTX | BioNTech | $5.29 | $9.71 | $15.97 | 64.47% | $2.47B | $4.59B | $7.16B | 55.90% | 05/09/2022 | Get Alert |
| BNTX | BioNTech | $1.87 | $8.19 | $13.93 | 70.09% | $411.87M | $4.31B | $6.33B | 46.82% | 03/30/2022 | Get Alert |
| BNTX | BioNTech | -$1.03 | $12.03 | $14.56 | 21.03% | $78.83M | $5.93B | $7.18B | 21.05% | 11/09/2021 | Get Alert |
| BNTX | BioNTech | -$0.42 | $8.91 | $12.97 | 45.57% | $45.99M | $3.84B | $6.39B | 66.54% | 08/09/2021 | Get Alert |
| BNTX | BioNTech | -$0.26 | $3.72 | $5.29 | 42.20% | $30.51M | $1.78B | $2.47B | 38.76% | 05/10/2021 | Get Alert |
| BNTX | BioNTech | -$0.28 | -$0.18 | $1.87 | 1138.89% | $31.08M | $224.87M | $411.87M | 83.16% | 03/30/2021 | Get Alert |
| BNTX | BioNTech | -$0.15 | -$0.42 | -$1.03 | -145.24% | $31.28M | $63.84M | $78.83M | 23.48% | 11/10/2020 | Get Alert |
| BNTX | BioNTech | — | -$0.28 | -$0.42 | -50.00% | — | $52.23M | $45.99M | -11.94% | 08/11/2020 | Get Alert |
| BNTX | BioNTech | — | -$0.27 | -$0.26 | 3.70% | — | $27.21M | $30.51M | 12.14% | 05/12/2020 | Get Alert |
| BNTX | BioNTech | — | -$0.14 | -$0.28 | -100.00% | — | $29.40M | $31.08M | 5.71% | 03/31/2020 | Get Alert |
BioNTech (BNTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-10 | $1.15 | $0.37 | 210.8 % |
| Q3 | 2024-11-04 | $0.89 | $-1.67 | 153.3 % |
| Q2 | 2024-08-05 | $-3.62 | $-2.20 | -64.5 % |
| Q1 | 2024-05-06 | $-1.42 | $-1.17 | -21.4 % |
BioNTech (BNTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-10 | $1.27B | $1.15B | 10.4 % |
| Q3 | 2024-11-04 | $1.37B | $639.12M | 114.0 % |
| Q2 | 2024-08-05 | $138.56M | $170.40M | -18.7 % |
| Q1 | 2024-05-06 | $203.74M | $460.50M | -55.8 % |
FAQ
When is BioNTech (NASDAQ:BNTX) reporting earnings?
BioNTech (BNTX) is scheduled to report earnings on May 5, 2025. The last reported earnings were for reported on March 10, 2025 for Q4.
What were the latest earnings per share (EPS) for BioNTech (NASDAQ:BNTX)?
The Actual EPS was $1.15, which beat the estimate of $0.37.
What were BioNTech’s (NASDAQ:BNTX) revenues?
The Actual Revenue was $1.3B, which beat the estimate of $1.1B.
Browse earnings estimates, EPS, and revenue on all stocks.